Use of Multiplex Allele-Specific Polymerase Chain Reaction (MAS-PCR) to Detect Multidrug-Resistant Tuberculosis in Panama
暂无分享,去创建一个
Thomas R. Ioerger | James C. Sacchettini | J. Sacchettini | T. Ioerger | Dalin Rifat | P. Karakousis | J. Pascale | Petros C. Karakousis | Edith Torres-Chavolla | Dalin Rifat | Elizabeth Y. Kim | Bing-Shao Chia | Fedora Lanzas | Aubrey Herrera | Christine Sailer | Purvaja Narayanaswamy | Viktor Einarsson | Jaime Bravo | Juan M. Pascale | Jaime Bravo | B. Chia | Fedora Lanzas | P. Narayanaswamy | E. Torres-Chavolla | Christine Sailer | A. Herrera | Viktor Einarsson
[1] Annelies Van Rie,et al. Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence Community , 2001, Journal of Clinical Microbiology.
[2] Thomas R. Ioerger,et al. Genome Analysis of Multi- and Extensively-Drug-Resistant Tuberculosis from KwaZulu-Natal, South Africa , 2009, PloS one.
[3] C. Çavuşoğlu,et al. Characterization of rpoB Mutations in Rifampin-Resistant Clinical Isolates of Mycobacterium tuberculosis from Turkey by DNA Sequencing and Line Probe Assay , 2002, Journal of Clinical Microbiology.
[4] E. Graviss,et al. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. , 2004, Journal of medical microbiology.
[5] S. Morris,et al. Exploring the Structure and Function of the Mycobacterial KatG Protein Using trans-Dominant Mutants , 2003, Antimicrobial Agents and Chemotherapy.
[6] R. O'brien,et al. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. , 2001, American journal of respiratory and critical care medicine.
[7] J. Farrar,et al. Mutations Prevalent among Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis Isolates from a Hospital in Vietnam , 2006, Journal of Clinical Microbiology.
[8] S. Cole,et al. The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis , 1992, Nature.
[9] Diana C. Rostirolla,et al. Bmc Microbiology , 2022 .
[10] Eduardo Gotuzzo,et al. Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.
[11] P. Karakousis. Mechanisms of Action and Resistance of Antimycobacterial Agents , 2009 .
[12] Honghai Wang,et al. Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Isolates from China , 2003, Journal of Clinical Microbiology.
[13] J. Musser,et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas , 1994, Journal of clinical microbiology.
[14] George M Church,et al. Tuberculosis Drug Resistance Mutation Database , 2009, PLoS medicine.
[15] Sang-Nae Cho,et al. rpoB Genotypes of Mycobacterium tuberculosis Beijing Family Isolates from East Asian Countries , 2002, Journal of Clinical Microbiology.
[16] J. Musser,et al. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[17] N. Lan,et al. Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[18] M. Noble,et al. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid. , 2002, Journal of molecular biology.
[19] I. Mokrousov,et al. High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia, 1996 to 2001 , 2002, Antimicrobial Agents and Chemotherapy.
[20] C. E. Barry,et al. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. , 2000, Microbes and infection.
[21] B. Foxman,et al. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. , 2005, Diagnostic microbiology and infectious disease.
[22] P. Small,et al. Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis , 2006, PLoS pathogens.
[23] E. Sim,et al. Cloning and Characterization of Arylamine N -Acetyltransferase Genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: Increased Expression Results in Isoniazid Resistance , 1999, Journal of bacteriology.
[24] Nclr. The Hispanic Population , 2003 .
[25] V. Govorun,et al. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. , 2007, The Journal of antimicrobial chemotherapy.
[26] Nalin Rastogi,et al. Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela , 2006 .
[27] R. Moellering,et al. Antimicrobial-drug resistance. , 1996, The New England journal of medicine.
[28] Teresa Quitugua,et al. Single Nucleotide Polymorphisms in Genes Associated with Isoniazid Resistance in Mycobacterium tuberculosis , 2003, Antimicrobial Agents and Chemotherapy.
[29] Yi-Wei Tang,et al. Prevalence of and Molecular Basis for Tuberculosis Drug Resistance in the Republic of Georgia: Validation of a QIAplex System for Detection of Drug Resistance-Related Mutations , 2007, Antimicrobial Agents and Chemotherapy.
[30] K. Castro,et al. Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. , 2007, American journal of respiratory and critical care medicine.
[31] Young Kil Park,et al. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. , 2005, Journal of microbiological methods.